| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/27/2011 | WO2011010737A1 Guide nucleic acid for cleavage of micro-rna |
| 01/27/2011 | WO2011010691A1 Polyion complex comprising phd2 expression inhibiting substance |
| 01/27/2011 | WO2011010583A1 Method for screening for oligonucleotide, and oligonucleotide library |
| 01/27/2011 | WO2010105251A3 Non-integrating retroviral vector vaccines |
| 01/27/2011 | WO2010090876A3 Satiation peptide administration |
| 01/27/2011 | WO2010045512A3 Processes and compositions for liposomal and efficient delivery of gene silencing therapeutics |
| 01/27/2011 | US20110021752 Tropoelastin Derivatives |
| 01/27/2011 | US20110021609 MicroRNA Signatures Associated with Cytogenetics and Prognosis in Acute Myeloid Leukemia (AML) and Uses Thereof |
| 01/27/2011 | US20110021608 Methods for nucleic acid transfer into cells |
| 01/27/2011 | US20110021605 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/27/2011 | US20110021603 TRPM-2 Antisense Therapy |
| 01/27/2011 | US20110021377 Use of a trpc channel for the treatment of a cardiovascular disease |
| 01/27/2011 | US20110021365 Nucleic Acid Binding Compounds Containing Pyrazolo[3,4-D]Pyrimidine Analogues of Purin-2,6-Diamine and Their Uses |
| 01/27/2011 | US20110020951 Purified sr-p70 protein |
| 01/27/2011 | US20110020928 Immunovectors which can be used for the intracellular and intranuclear transport |
| 01/27/2011 | US20110020901 Methods of Making Viral Particles Having a Modified Cell Binding Activity and Uses Thereof |
| 01/27/2011 | US20110020790 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020348 Pharmaceutical compositions and methods using secreted frizzled related protein |
| 01/27/2011 | US20110020321 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020229 Multi-Component Biological Transport Systems |
| 01/27/2011 | US20110020226 Particle structures comprising sterols and saponins |
| 01/27/2011 | CA2768947A1 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 01/26/2011 | EP2278022A2 Expression vectors, transfection systems, and method of use thereof |
| 01/26/2011 | EP2278021A2 Expression vectors, transfection systems, and method of use thereof |
| 01/26/2011 | EP2278020A2 Antibody gene transfer and recombinant AAV therefor |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278012A2 Avirulent, immunogenic flavivirus chimeras |
| 01/26/2011 | EP2278011A2 Neisseria meningitidis antigens |
| 01/26/2011 | EP2278007A1 Conserved neisserial antigens |
| 01/26/2011 | EP2278006A2 Neisserial antigens |
| 01/26/2011 | EP2278005A2 Fuctional and hyperfunctional sirna |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277998A1 Urate oxidase |
| 01/26/2011 | EP2277907A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277906A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277905A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277904A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277903A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277902A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277901A2 Differential in tumour gene products and use of same |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277893A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277892A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/26/2011 | EP2277887A2 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 01/26/2011 | EP2277552A1 Mnk kinase proteins and diabetes |
| 01/26/2011 | EP2277531A1 Treatment of cns damage |
| 01/26/2011 | EP2277522A2 Methods for increasing or decreasing bone density and identifying molecules |
| 01/26/2011 | EP2277508A1 Emulation of lipoprotein structures |
| 01/26/2011 | EP2276778A1 Neurotrophic factor manf and uses thereof |
| 01/26/2011 | EP2276501A2 Methods and compositions for genetic and retinal disease |
| 01/26/2011 | EP2276475A1 Biodegradable nanoshells for delivery of therapeutic and/or imaging molecules |
| 01/26/2011 | EP1912665B1 Vaccine against feline calicivirus (fcv) comprising a fcv capsid protein or an isolated fcv capsid protein comprising protein sequence seq id no: 13 or protein sequences having at least 95% identity thereto. |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1539956B1 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 01/26/2011 | EP1404365B1 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 01/26/2011 | CN101960009A Cationic siRNAs, synthesis and use for interfering RNA |
| 01/26/2011 | CN101957379A HPPCn antibody, antisense oligonucleotide and application of RNA interference in tumor diagnosis and treatment |
| 01/26/2011 | CN101955997A Compositions and method for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 01/26/2011 | CN101955976A Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 01/26/2011 | CN101955975A Construction of si RNA expression vector of tissue inhibitor of metalloproteinases (TIMPs) and application in treatment of cirrhosis |
| 01/26/2011 | CN101955956A Eimeria tenella calcium-dependent protein kinase gene and application thereof |
| 01/26/2011 | CN101955941A Porcine interferon gene family and application thereof in blue-ear porcine disease resistant medicament and vaccine adjuvant |
| 01/26/2011 | CN101955545A Multi-target recombination gene and application of protein thereof in preventing and treating infection of helicobacter pylori |
| 01/26/2011 | CN101955543A Nerve growth factor bound with laminin, and coding gene and application thereof |
| 01/26/2011 | CN101954095A Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 01/26/2011 | CN101954094A Application of miR-199a-3p in preparation of medicine for resisting hepatitis B virus |
| 01/26/2011 | CN101954093A Hepatitis B nucleic acid vaccine and construction method thereof |
| 01/26/2011 | CN101954092A Genetic engineering vaccine of lymphocystis disease of flounder paralichthys olivaceus and production method thereof |
| 01/26/2011 | CN101954077A Expression plasmid adjuvant for enhancing chemotherapeutic effect of tumor chemotherapeutics and preparation method thereof |
| 01/26/2011 | CN101954066A Medicament for promoting repair of peripheral nerve injury |
| 01/26/2011 | CN101624596B External guide sequence of target c-myc cancer gene |
| 01/26/2011 | CN101481691B Trichinella spiralis 70KDa heat shock protein and use thereof |
| 01/26/2011 | CN101440379B Obtaining method and use of novel oncolytic adenovirus construct with selective tumor blockage STAT3 |
| 01/26/2011 | CN101348799B Construction method and pharmaceutical use of microRNA adenovirus expression plasmid for severe hepatitis related gene hfg12, hFas and hTNFR1 |
| 01/26/2011 | CN101205542B Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof |
| 01/26/2011 | CN101173294B Gene tiny chain carrier, construction method and application of the same |
| 01/26/2011 | CN101164624B Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 01/26/2011 | CN101117637B Strict hypoxia targeting carrier and uses thereof |
| 01/25/2011 | USRE42072 High transport rates of hormones delivered across cell membranes, facilitating more efficient delivery of drugs and diagnostic agents by using a viscous fluid comprising a polysaccharide a form of hydrogel, lipogel or sols; drug delivery to mucous membranes; gastrointesinal systems |
| 01/25/2011 | US7875733 Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation |
| 01/25/2011 | US7875677 Micellar drug delivery systems for hydrophobic drugs |
| 01/25/2011 | US7875594 Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | US7875274 identifying therapeutically responsive phenotype in brain tumor cells by measuring expression of TNFAIP3 gene (tumor necrosis factor alpha-induced protein 3) |
| 01/25/2011 | US7875255 Highly dispersible inorganic nanoparticles with a low aggregation property, even though the nanoparticles are covered with labeled compounds; hydroxyapatite-modifiedpolyethyleneimine modified by biological labels such asenzymes, antibodies, colored proteins, fluoroproteins, DNA, RNA; antiagglomerants |
| 01/25/2011 | CA2457856C Sulphonated meso-tetraphenyl chlorins and their use as therapeutic agents |
| 01/25/2011 | CA2441834C Lipid profile modulation |
| 01/25/2011 | CA2410000C Compositions and methods comprising plasmid dna for wound healing and for repairing and regenerating tissue |
| 01/25/2011 | CA2384425C Methods and compositions for delivery of pharmaceutical agents |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2369826C Therapy of cardiac insufficiency |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2338186C Tumor necrosis factor-gamma |
| 01/25/2011 | CA2292378C A method of inhibiting cancer cell growth using a vector expressing prb2/p130 |
| 01/25/2011 | CA2281858C A method for making infectious, propagation defective tr339 virus particles and helper cells therefor |
| 01/25/2011 | CA2174098C Method of inducing and maintaining neuronal cells |
| 01/20/2011 | WO2011009082A2 Compositions comprising human rhbdf1-modulating nucleic acids and methods of use |